ArticleScientific reports2026
Transcriptomic profiling of HBV transgenic mouse livers reveals ZBP1-associated necroptotic signaling.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genetically informed prioritization of immune checkpoint-associated genes in head and neck cancer highlights HGF and AKT1.Functional & integrative genomics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Although transcriptome studies have been performed in cell culture models of HBV infection, the in vivo hepatic transcriptional response to persistent HBV expression remains incompletely characterized. In addition, whether HBV is associated with activation of necroptotic signaling in the liver has not been fully clarified. Therefore, this study aimed to: (1) define transcriptomic alterations in livers from an HBV transgenic mouse model; and (2) explore whether ZBP1-associated necroptotic signaling is present in HBV-Tg livers by integrating RNA-seq, bioinformatic analysis, and biochemical validation. We utilized an HBV transgenic mouse model and characterized it by measuring serum HBV DNA, HBsAg, AST, ALT, and TBIL levels and by performing hematoxylin and eosin (H&E) staining. Subsequently, the expression of protein-coding genes in HBV transgenic and control mice was analyzed by next-generation RNA sequencing (RNA-seq). Differentially expressed genes (DEGs) were identified using EdgeR with thresholds of |log2(fold change)| > 1 and P value < 0.05. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed on the DEGs. A protein-protein interaction (PPI) network was constructed based on the STRING database, and PPI modules were analyzed using the MCODE plugin in Cytoscape. Finally, we evaluated ZBP1-associated necroptotic signaling by examining the protein levels of ZBP1 and phosphorylated RIPK3/MLKL by Western blot. We identified 815 candidate differentially expressed genes, including 412 upregulated and 403 downregulated genes in HBV-Tg livers compared with control livers. KEGG pathway analysis indicated enrichment of immune-related pathways, metabolic pathways, and viral infection-related pathways. Zbp1 drew further attention because it was increased in HBV-Tg livers and located within an interferon/innate immune-related PPI module. At the protein level, ZBP1, p-RIPK3, and p-MLKL were increased in HBV-Tg livers. These findings suggest elevated ZBP1-associated necroptosis-related markers in the HBV-Tg liver model. We profiled gene expression in livers from HBV-Tg and control mice using RNA-seq and identified candidate DEGs, GO terms, and pathway terms associated with HBV-related liver responses. Our data support an association between HBV-Tg liver status and increased ZBP1, p-RIPK3, and p-MLKL expression. However, additional functional studies are required to determine cell specificity, causal direction, and the contribution of this signaling axis to liver injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.